Methods for treating disorders associated with hyperlipidemia in a mammal

Details for Australian Patent Application No. 2006304534 (hide)

Owner Aegerion Pharmaceuticals

Inventors Wisler, Gerald L.

Agent Pizzeys

Pub. Number AU-A-2006304534

PCT Pub. Number WO2007/047725

Priority 60/727,664 18.10.05 US; 60/788,616 03.04.06 US

Filing date 18 October 2006

Wipo publication date 26 April 2007

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/437 (2006.01)

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047725 Priority application(s): WO2007/047725

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304536-Suspended deck for liquid natural gas tank

2006304531-Methods for treating disorders associated with hyperlipidemia in a mammal